Abstract
Application of microencapsulation to the immunoisolation of pancreatic islets holds promise for expanding the use of islet transplantation as a treatment option for Type 1 diabetes. It is generally believed that successful development of a reliable methodology will ideally allow for transplantation of pancreatic islets that are protected from the immune system, thereby obviating the need for the use of immunosuppressive drugs and their attendant side effects. In addition, this technology has the potential to expand the donor pool as islets from nonhuman donors could be used as xenografts in human patients. The complex polysaccharide, alginate, has been the most widely used polymer for microencapsulation of islets. However, it is known that alginate lacks appreciable permselectivity to confer immunoisolation of encapsulated islets, thus necessitating the routine permselective coating of alginate microbeads with polymers of amino acids, mainly, poly-l-lysine (PLL) and poly-l-ornithine (PLO). The protocol described in this chapter outlines the steps we have used in our studies on perm-selective coating of alginate microbeads for islet transplantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053
www.diabetes.org Data from the National Diabetes Statistics Report, 2014 (released June 10, 2014).
Duck JH, Sutherland DER (2010) Gut Liver 4(4):450–465
Hakim NS (2002) Pancreatic transplantation for patients with Type I diabetes. HPB (Oxford) 4(2):59–61
Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16(1):35–39
Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343(4):230–238
Kendall WF, Collins BH, Opara EC (2001) Islet cell transplantation for the treatment of diabetes mellitus. Expert Opin Biol Ther 1(1):109–119
Opara EC, McQuilling JP, Farney AC (2013) Microencapsulation of pancreatic islets for use in a bioartificial pancreas. Methods Mol Biol 1001:261–266
Ching DC, Harland RC, Collins BH, Kendall W, Hobbs H, Opara EC (2001) A reliable method for isolation of viable porcine islet cells. Arch Surg 136:276–279
Darrabie MD, Kendall WF, Opara EC (2005) Characteristics of poly-L-ornithine-coated alginate microcapsules. Biomaterials 26(34):6846–6852
Hobbs H, Kendall W, Darrabie M, Collins B, Bridges S, Opara EC (2000) Substitution of polyornithine for polylysine in alginate microcapsules. Diabetes 49(Suppl 1):A111
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kendall, W.F., Opara, E.C. (2017). Polymeric Materials for Perm-Selective Coating of Alginate Microbeads. In: Opara, E. (eds) Cell Microencapsulation. Methods in Molecular Biology, vol 1479. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6364-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6364-5_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6362-1
Online ISBN: 978-1-4939-6364-5
eBook Packages: Springer Protocols